187 related articles for article (PubMed ID: 16596176)
1. Recurrent NMYC copy number gain and high protein expression in basal cell carcinoma.
Freier K; Flechtenmacher C; Devens F; Hartschuh W; Hofele C; Lichter P; Joos S
Oncol Rep; 2006 May; 15(5):1141-5. PubMed ID: 16596176
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of novel sonic hedgehog gene mutations identified in basal cell carcinomas from xeroderma pigmentosum patients.
Couvé-Privat S; Le Bret M; Traiffort E; Queille S; Coulombe J; Bouadjar B; Avril MF; Ruat M; Sarasin A; Daya-Grosjean L
Cancer Res; 2004 May; 64(10):3559-65. PubMed ID: 15150112
[TBL] [Abstract][Full Text] [Related]
3. NAV3 copy number changes and target genes in basal and squamous cell cancers.
Maliniemi P; Carlsson E; Kaukola A; Ovaska K; Niiranen K; Saksela O; Jeskanen L; Hautaniemi S; Ranki A
Exp Dermatol; 2011 Nov; 20(11):926-31. PubMed ID: 21995814
[TBL] [Abstract][Full Text] [Related]
4. Expression of rasGTPase activating protein in basal cell carcinoma of the skin.
Barshack I; Goldberg I; Davidson B; Ravid A; Schiby G; Kopolovic J; Leviav A; Friedman E
Mod Pathol; 1998 Mar; 11(3):271-5. PubMed ID: 9521474
[TBL] [Abstract][Full Text] [Related]
5. Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancer.
Utikal J; Udart M; Leiter U; Kaskel P; Peter RU; Krähn G
Cancer Lett; 2005 Mar; 219(2):197-204. PubMed ID: 15723720
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma.
Ansarin H; Daliri M; Soltani-Arabshahi R
Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476
[TBL] [Abstract][Full Text] [Related]
7. Microarray profiles of human basal cell carcinoma: insights into tumor growth and behavior.
Howell BG; Solish N; Lu C; Watanabe H; Mamelak AJ; Freed I; Wang B; Sauder DN
J Dermatol Sci; 2005 Jul; 39(1):39-51. PubMed ID: 15978418
[TBL] [Abstract][Full Text] [Related]
8. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N
Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330
[TBL] [Abstract][Full Text] [Related]
9. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
[TBL] [Abstract][Full Text] [Related]
11. Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma.
Freier K; Knoepfle K; Flechtenmacher C; Pungs S; Devens F; Toedt G; Hofele C; Joos S; Lichter P; Radlwimmer B
Genes Chromosomes Cancer; 2010 Jan; 49(1):9-16. PubMed ID: 19787784
[TBL] [Abstract][Full Text] [Related]
12. Nodular basal cell carcinoma is associated with increased hyaluronan homeostasis.
Tzellos TG; Kyrgidis A; Vahtsevanos K; Triaridis S; Printza A; Klagas I; Zvintzou E; Kritis A; Karakiulakis G; Papakonstantinou E
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):679-87. PubMed ID: 20849445
[TBL] [Abstract][Full Text] [Related]
13. A role of PDGFRalpha in basal cell carcinoma proliferation.
Xie J; Aszterbaum M; Zhang X; Bonifas JM; Zachary C; Epstein E; McCormick F
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9255-9. PubMed ID: 11481486
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays.
O'Driscoll L; McMorrow J; Doolan P; McKiernan E; Mehta JP; Ryan E; Gammell P; Joyce H; O'Donovan N; Walsh N; Clynes M
Mol Cancer; 2006 Dec; 5():74. PubMed ID: 17173689
[TBL] [Abstract][Full Text] [Related]
16. Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles.
Yu M; Zloty D; Cowan B; Shapiro J; Haegert A; Bell RH; Warshawski L; Carr N; McElwee KJ
J Invest Dermatol; 2008 Jul; 128(7):1797-805. PubMed ID: 18200053
[TBL] [Abstract][Full Text] [Related]
17. Insight into the pathogenesis of sporadic basal cell carcinoma.
Holíková Z; Massi D; Lotti T; Hercogová J
Int J Dermatol; 2004 Dec; 43(12):865-9. PubMed ID: 15569004
[TBL] [Abstract][Full Text] [Related]
18. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-kappaB/interleukin-6 pathway.
Chu CY; Cha ST; Lin WC; Lu PH; Tan CT; Chang CC; Lin BR; Jee SH; Kuo ML
Carcinogenesis; 2009 Feb; 30(2):205-13. PubMed ID: 18849299
[TBL] [Abstract][Full Text] [Related]
19. [Specific characteristics of skin basal cell carcinoma invasion].
Doĭkova NG; Chernyĭ AP; Chipysheva TA; Gel'shteĭn VI
Arkh Patol; 2000; 62(3):29-33. PubMed ID: 10897434
[TBL] [Abstract][Full Text] [Related]
20. The expression of p63 in basal cell carcinomas and association with histological differentiation.
Bircan S; Candir O; Kapucoglu N; Baspinar S
J Cutan Pathol; 2006 Apr; 33(4):293-8. PubMed ID: 16630179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
